Regard

Regard, formerly HealthTensor, develops an AI-powered clinical diagnosis and documentation platform that integrates with the electronic health record (EHR). The software ingests and maps the full set of data in a patient's chart, applies proprietary clinically validated algorithms to recommend diagnoses with supporting evidence, and generates a draft clinical note in the physician's preferred style before the physician enters the room. The company frames the problem it addresses as a data-access gap: it cites research that physicians review roughly 3% of available patient data, against an average of about 50,000 data points per patient, and positions its platform as reviewing 100% of the chart.

The platform is organized into four workflows: Clinical Notes (diagnostic support and note generation), Mid-Revenue Cycle (denial prevention and revenue capture), HCC Capture (risk adjustment and quality gap identification), and Screening (identifying patients eligible for procedures, consults, or interventions). It is complemented by analytics and reporting used to demonstrate adoption and financial impact. Historically focused on hospital medicine and hospitalists — who see roughly 50-55% of admitted patients — Regard announced in March 2026 an expansion into cardiology and surgical service lines, described as a first step toward supporting all inpatient specialties.

The company has also extended its product beyond chart data: in July 2025 it announced a platform combining EHR chart data with physician-patient conversations to recommend diagnoses, and in 2023 released functionality built on OpenAI's GPT-4, including a chatbot named Max.

Founding story

Regard was co-founded by Eli Ben-Joseph, who serves as CEO; investor commentary also references co-founder Nate. The company operated previously under the name HealthTensor and counts Techstars among its early investors.

Business model

Regard sells its EHR-integrated diagnosis and documentation platform to hospitals and health systems on an enterprise basis, deploying to clinicians across service lines and supporting deployments with impact analytics that quantify adoption, documentation quality, and financial return (for example ROI per user and denials prevented).

Enterprise sales to health systems; the value proposition presented to buyers is incremental captured revenue, prevented denials, improved CC/MCC and HCC capture, and reduced documentation queries.

Traction

Regard reports use by thousands of clinicians across more than 150 hospitals in 20+ states, covering more than 1 million patient encounters, with 12,993,284 recommended diagnoses accepted by clinicians as of 2026. Named customers include Cedars-Sinai, Banner Health, Sentara Health, WakeMed, Penn Highlands, The Guthrie Clinic, Tampa General, Montefiore, Memorial Hermann, Ascension, AdventHealth and others. Reported customer outcomes include a 17% increase in CC/MCC capture and 4x ROI per user at Sentara, $9.3M in denials prevented at a North Carolina health system, $10M gained at WakeMed, $7M revenue increase at Penn Highlands, and $50M+ in revenue earned at an Arizona health system. Earlier milestones include two million conditions diagnosed (January 2024), three million diagnoses surfaced and $50M in incremental partner revenue as of mid-2024, and five million medical conditions caught (February 2025).

Latest developments

In March 2026 Regard announced the expansion of its platform from hospital medicine into cardiology and surgical service lines, already in pilot with specialist clinicians and involving The Guthrie Clinic, as a first step toward covering all admitted patients. The same month it showcased its Microsoft Dragon Copilot partnership at HIMSS 2026. The company is hosting the Regard Summit 2027 in Miami on January 25-27, 2027.